Antibody Patenting after Amgen v. Sanofi: a webinar on U.S. and European Perspectives

Mathys & Squire Of Counsel, Hazel Ford, will once again be joining a panel of patent attorneys in an encore webinar discussing: Antibody Patenting after Amgen v. Sanofi: U.S. and European Perspectives followed by a live question and answer session. 

The panel will examine the patentability requirements in the USPTO and EPO for claiming a broad genus of antibodies, recent case law that could impact those claims, and how to best protect antibody inventions in light of the latest developments. Topics of discussion will include: 

• How broadly can the applicant claim? How much support is needed on a filing?
• What are the differences between U.S. requirements and EPO requirements?
• What is a sufficient description of a genus? Can functional language be included?
• When can post-filing data be used?

Book your place by clicking here.

Thursday, December 20th 2018

1:00pm-2:30pm EST | 18:00 – 19:30 GMT